<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49-ijerph-17-01395">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nagu</surname>
    <given-names>T.J.</given-names>
   </name>
   <name>
    <surname>Aboud</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Matee</surname>
    <given-names>M.I.</given-names>
   </name>
   <name>
    <surname>Maeurer</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Fawzi</surname>
    <given-names>W.W.</given-names>
   </name>
   <name>
    <surname>Mugusi</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: A prospective multicentre study</article-title>
  <source>J. Antimicrob. Chemother.</source>
  <year>2017</year>
  <volume>72</volume>
  <fpage>876</fpage>
  <lpage>881</lpage>
  <pub-id pub-id-type="doi">10.1093/jac/dkw503</pub-id>
  <pub-id pub-id-type="pmid">27999054</pub-id>
 </element-citation>
</ref>
